HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard C Semelka Selected Research

gadoversetamide (OptiMARK)

1/2019Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard C Semelka Research Topics

Disease

16Neoplasms (Cancer)
03/2017 - 02/2002
9Nephrogenic Fibrosing Dermopathy
01/2019 - 09/2008
8Neoplasm Metastasis (Metastasis)
01/2015 - 02/2002
7Hepatocellular Carcinoma (Hepatoma)
03/2017 - 09/2004
4Pancreatic Neoplasms (Pancreatic Cancer)
02/2009 - 05/2005
3Lymphadenopathy
12/2014 - 06/2003
3Chronic Pancreatitis
10/2014 - 05/2005
3Fibrosis (Cirrhosis)
11/2012 - 02/2005
2Hypersensitivity (Allergy)
01/2022 - 05/2005
2Pancreatitis
10/2014 - 05/2005
2Breast Neoplasms (Breast Cancer)
10/2014 - 05/2004
2Disease Progression
07/2012 - 05/2004
2Liver Diseases (Liver Disease)
11/2009 - 08/2004
2Carcinoma (Carcinomatosis)
05/2005 - 02/2005
1Symptom Flare Up
01/2021
1Human Influenza (Influenza)
01/2021
1Chronic Renal Insufficiency
09/2015
1Vomiting
04/2015
1Acquired Immunodeficiency Syndrome (AIDS)
07/2014
1Pheochromocytoma
07/2014
1Adenoma (Adenomas)
07/2014
1Adrenocortical Carcinoma
07/2014
1Focal Nodular Hyperplasia
04/2013
1Fatty Liver
11/2011
1Liver Failure
11/2011
1Non-alcoholic Fatty Liver Disease
11/2011
1Neoplasms, Cystic, Mucinous, and Serous
12/2010
1Hepatitis C
07/2010
1Alcoholic Hepatitis
07/2010
1Pulmonary Embolism
11/2009
1Leiomyoma (Uterine Fibroids)
12/2008
1Thrombosis (Thrombus)
11/2006
1Infections
05/2005
1Islet Cell Adenoma (Islet Cell Tumors)
05/2005
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2005
1Hypoxia (Hypoxemia)
02/2005
1Edema (Dropsy)
02/2005
1Abscess
02/2005
1Intraabdominal Infections
08/2004
1Sarcoma (Soft Tissue Sarcoma)
07/2004
1Malignant Mesothelioma
11/2003
1Renal Cell Carcinoma (Grawitz Tumor)
07/2003
1Atrophy
03/2003
1Malacoplakia
10/2002

Drug/Important Bio-Agent (IBA)

23GadoliniumIBA
01/2021 - 03/2003
9Contrast MediaIBA
01/2021 - 05/2004
3gadobenic acid (gadobenate dimeglumine)FDA Link
09/2015 - 03/2011
3Capsules (Microcapsules)IBA
12/2014 - 11/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2005 - 09/2004
1montelukast (Singulair)FDA Link
01/2022
1SteroidsIBA
01/2022
1Histamine Antagonists (Antihistamines)IBA
01/2022
1AcidsIBA
01/2021
1CytokinesIBA
01/2021
1LigandsIBA
01/2019
1gadoversetamide (OptiMARK)FDA Link
01/2019
1gadodiamide (Omniscan)FDA Link
01/2019
1gadoteridol (Prohance)FDA Link
09/2015
1gadoterate meglumineIBA
04/2015
1Aromatase InhibitorsIBA
10/2014
1Indicators and Reagents (Reagents)IBA
07/2014
1Fetal Proteins (Fetoprotein)IBA
07/2013
1gadolinium ethoxybenzyl DTPAFDA Link
04/2013
1Biological ProductsIBA
11/2012
1Biomarkers (Surrogate Marker)IBA
07/2011
1Gadolinium DTPA (Magnevist)FDA Link
10/2005
1Anabolic Androgenic SteroidsIBA
08/2005
1IodineIBA
05/2005
1CreatinineIBA
05/2005
1Ethanol (Ethyl Alcohol)IBA
05/2005
1Vascular Endothelial Growth FactorsIBA
02/2005
1interleukin-24 (ST16)IBA
02/2005
1Hormones (Hormone)IBA
05/2004
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
08/2003

Therapy/Procedure

9Therapeutics
03/2017 - 02/2002
8Liver Transplantation
11/2011 - 02/2002
3Drug Therapy (Chemotherapy)
02/2005 - 02/2002
2Transplantation
11/2006 - 07/2003
1Chelation Therapy (Therapy, Chelation)
01/2021
1Conservative Treatment
12/2010
1Radiofrequency Ablation
12/2010
1Hysterectomy
12/2008
1Thrombectomy
11/2006
1Contraindications
05/2005
1Radiotherapy
02/2005
1Hepatectomy
09/2004
1Laser Therapy (Surgery, Laser)
02/2002